Week Ending May 3, 2021

Genomic Study Points to New Treatment Approaches for Advanced Small-Cell Lung Cancer
“COLUMBUS, Ohio – A new study of advanced small-cell lung cancer (SCLC) led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has identified molecular patterns linked to patients developing resistance to certain therapies.”

Lung Cancer Survival Continues to Rise With Immunotherapy
“Twice as many patients with advanced NSCLC alive at 5 years with pembrolizumab vs chemo”

Personalized Treatments Advance Survival Outcomes for Patients With Lung Cancer
“Over the last year, our world has been consumed by the coronavirus disease 2019 (COVID-19) pandemic. The medical community has dedicated vast amounts of energy and resources toward the viral global crisis, but the incidence of other illnesses is unrelenting.”

Early Introduction to Supportive Care Greatly Benefits Older Patients With Lung Cancer
“When Frank Giunta, 82, of Collegeville, Pennsylvania, was diagnosed with non-small cell lung cancer (NSCLC) in August 2020, he was assured by his caregivers at Penn Medicine’s Abramson Cancer Center in Philadelphia that he would not be alone during his treatment journey. Accompanying him would be a multidisciplinary supportive care team dedicated to ensuring that everything went smoothly, with as little impact as possible on his quality of life.”

Winship and partners work to expand lung cancer services for veterans in the Southeast
“With new funding from the Veterans Affairs VA Lung Precision Oncology Program, Winship Cancer Institute of Emory University (Winship) will provide thoracic oncology expertise to help three VA medical centers expand access to high quality, disease altering lung cancer clinical trials to veterans in the Southeast.”

Data Show That PD-L1 Status Affects the Efficacy of Pembrolizumab in Non–Small Cell Lung Cancer
“Ravi Salgia, MD, PhD, the Arthur & Rosalie Kaplan chair in Medical Oncology at City of Hope discussed the case of a 59-year-old patient with non–small cell lung cancer during a virtual Targeted Oncology Case-Based Roundtable event.”

You Should Be Scanned for Lung Cancer if You’ve Done This, Panel Says
“Big news for smokers and even non-smokers: The eligibility for a lung exam should expand, according to March statement from the U.S. Preventive Services Task Force. “Lung cancer is the second most common cancer and the leading cause of cancer death in the US,” they say.”

How The Guidelines Have Changed Regarding Lung Cancer Early Detection Efforts
“Lung cancer is the leading cause of U.S. cancer deaths. The U.S. Preventive Services Task Force has expanded screening guidelines in an effort to help increase early detection rates. On CBSN Denver, Dr. Surit Sharma, Pulmonologist at Sky Ridge Medical Center, explained the new guidelines.”

Bio-Marker Testing leads to Lung Cancer Survival Rates Rising
“A new campaign hopes to educate the public about bio-marker testing that could save lives.”